Drug makers’ sales forces have continued to shrink over the last few years. As the shift from primary fields to specialty arenas and the loss of patent protection for major products have transformed drug makers’ product mix, fewer sales reps…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Study Group Postpones Decision on Relief System for Victims of Health Damages Due to Anticancer Drugs
November 21, 2011
-
REGULATORY After Delay, CSIMC Recommends Listing of Ilaris for Treatment of CAPS
November 21, 2011
-
ORGANIZATION 6 Indian Generics Companies Including Zydus Form Association, to Start Operations This Month
November 18, 2011
-
BUSINESS Teva to Merge Taiyo, Kowa-Teva, Establish “Teva Pharma Japan” in Mid-2012
November 18, 2011
-
BUSINESS Fujifilm, Kyowa Kirin to Set Up Joint Venture for Biosimilars in 2012
November 17, 2011
-
REGULATORY CSIMC Recommends Listing of 9 Products Including Imusera; Recommendation Put on Hold for Ilaris
November 17, 2011
-
REGULATORY High Court Turns Down Iressa Compensation Appeal
November 16, 2011
-
REGULATORY 7-Drug Rule Should Be Relaxed or Eliminated to Promote GE Name Prescribing: Dr Adachi of CSIMC
November 16, 2011
-
BUSINESS Japan’s Jul-Sep 2011 Ethical Drug Market Grows 7.7%: IMS Japan
November 15, 2011
-
BUSINESS Otsuka Forms Alliance with Lundbeck in CNS Field
November 14, 2011
-
BUSINESS Top-3 GE Makers Report 10.4% Increase in Sales; Pace Down from Year Before
November 11, 2011
-
REGULATORY MHLW Proposes Raising GE Dispensing Rates to Receive Upper Premiums for GE Dispensing Systems
November 10, 2011
-
REGULATORY Applications for “Regulatory Strategy Consultation” Increasing Rapidly: Mr Isobe of PMDA
November 10, 2011
-
BUSINESS Operating Profit Rate for Top-4 Wholesalers Slips to 0.39% in April-September
November 9, 2011
-
BUSINESS Astellas, RIKEN to Explore, Jointly Develop Novel Drug Targets for AD
November 9, 2011
-
BUSINESS Towa Pharmaceutical Developing Lipitor Generic Version OD Tablets
November 9, 2011
-
BUSINESS Towa Pharmaceutical’s New Business Plan is “Groundwork for Future Progress”
November 8, 2011
-
BUSINESS Suzuken President Ota Says Wholesale Business Recovery Crucial
November 8, 2011
-
BUSINESS 8 of 10 Leading Drug Makers Report Declines in 1st-Half Sales
November 7, 2011
-
REGULATORY CSIMC Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 4, 2011
ページ
If you were able to make more money at a company you found less desirable than your current one, would it be worth it? Conversely, would you move to a better company and a better role and accept less pay?…
The average ratio of female employees at managerial posts stood at just 12.5% at pharmaceutical companies operating in Japan, a Jiho survey revealed. While foreign drug makers had an average 25.0%, the ratio came to as low as 9.8% for…
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…